{"schema_version":"secwatch.filing_event.v1","accession":"0001753926-23-001017","form_type":"8-K","ticker":"LIPO","cik":"0001347242","company_name":"LIPELLA PHARMACEUTICALS INC.","filed_at":"2023-08-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.675088+00:00","generated_at":"2026-06-12T01:12:06.714988+00:00","sec_items":["1.01","5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Lipella raises CEO and CMO salaries by $50k each","bullets":["CEO Jonathan Kaufman annual base salary increased by $50,000 to $233,300 effective August 4, 2023.","CMO Michael Chancellor annual base salary increased by $50,000 to $225,000 effective August 4, 2023.","Both amendments executed on August 4, 2023; all other terms of existing employment agreements remain unchanged.","The salary increases are reflected in amendments to employment agreements originally dated July 17, 2020."],"urls":{"canonical":"https://secwatch.observer/filing/0001753926-23-001017","json":"https://secwatch.observer/filing/0001753926-23-001017.json","markdown":"https://secwatch.observer/filing/0001753926-23-001017.md","text":"https://secwatch.observer/filing/0001753926-23-001017.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1347242/000175392623001017/0001753926-23-001017-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1347242/000175392623001017/g083697_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T01:12:06.714988+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}